Internal mammary artery grafting for coronary hypoperfusion in children
1Department of Cardiovascular Surgery, Baskent University, Istanbul, Turkey. canvuran@hotmail.com
Insights
Internal mammary artery bypass grafting is a safe and effective procedure for children experiencing coronary artery issues. This study shows no operative mortality and successful graft patency in pediatric patients.
Area of Science:
- Pediatric Cardiac Surgery
- Vascular Surgery
- Cardiology
Background:
- Pediatric coronary artery bypass is crucial for managing ischemic complications from Kawasaki disease, congenital anomalies, and iatrogenic issues.
- Internal mammary artery (IMA) grafting is a potential revascularization strategy in pediatric patients.
Purpose of the Study:
- To evaluate the outcomes of myocardial revascularization using the internal mammary artery in pediatric patients.
- To assess the safety and efficacy of IMA bypass grafting in infants and children.
Main Methods:
- Myocardial revascularization was performed in 6 pediatric patients using the internal mammary artery.
- Patient ages ranged from 7 days to 10 years.
- Outcomes were reviewed postoperatively.
Main Results:
- No operative mortality was observed in the study cohort.
- All coronary bypass grafts remained patent from 3 months to 3 years postoperatively.
- No patients experienced recurrent angina or signs of myocardial ischemia.
Conclusions:
- Internal mammary artery bypass grafting is a successful procedure in infants and children, yielding good clinical results.
- While long-term patency and distal anastomosis growth require further investigation, historical data suggests favorable outcomes up to 25 years.
Background:
Pediatric coronary artery bypass is performed for ischemic complications of Kawasaki disease, congenital coronary anomalies, and iatrogenic pediatric coronary artery problems.
Methods:
We performed myocardial revascularization using the internal mammary artery in 6 children. A review of outcomes is presented here. Patient ages ranged from 7 days to 10 years.
Results:
There was no operative mortality. All coronary bypass grafts were patent at 3 months to 3 years postoperatively. No patient had recurrent angina or showed signs of myocardial ischemia.
Conclusion:
Internal mammary artery bypass grafting can be successfully performed in infants and children with good results. Long-term patency and growth of the anastomosis of the distal vessel are not clear, but good clinical and angiographic results have been reported even after 25 years.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
